Evidence for the role of 34‐kDa galactoside‐binding lectin in transformation and metastasis
暂无分享,去创建一个
V. Hogan | A. Raz | N. Shah | Daguang Zhu | T. Raz | P. Carmi | R. Karkash | G. Pazerini | Tirza Raz
[1] N. Mazurek,et al. A mutant protein kinase C that can transform fibroblasts , 1989, Nature.
[2] N. Sharon,et al. Lectins as cell recognition molecules. , 1989, Science.
[3] I. Fidler,et al. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras. , 1989, Cancer research.
[4] R. Wilson,et al. Molecular aspects of the metastatic cascade. , 1989, Biochimica et biophysica acta.
[5] A. Raz,et al. Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. , 1989, Cancer research.
[6] R. Miskin,et al. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells , 1989, Molecular and cellular biology.
[7] D. Dowbenko,et al. Cloning of a lymphocyte homing receptor reveals a lectin domain , 1989, Cell.
[8] I. Weissman,et al. Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. , 1989, Science.
[9] B. Seed,et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.
[10] J. L. Wang,et al. Biochemical and immunological comparisons of carbohydrate-binding protein 35 and an IgE-binding protein. , 1989, The Journal of biological chemistry.
[11] G. Nicolson. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.
[12] I. Weinstein,et al. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. , 1988, Cancer research.
[13] A. Radler‐Pohl,et al. Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with dna from liver metastases of human colon carcinoma , 1988, International journal of cancer.
[14] A. Raz,et al. Expression of two different endogenous galactoside-binding lectins sharing sequence homology. , 1988, Cancer research.
[15] A. Avivi,et al. Cloning and expression of cDNA for two endogenous UV-2237 fibrosarcoma lectin genes. , 1987, Experimental cell research.
[16] R. Kerbel,et al. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras. , 1987, Oncogene.
[17] R. Lotan,et al. Transformation‐related changes in the expression of endogenous cell lectins , 1987, International journal of cancer.
[18] R. Lotan,et al. Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. , 1986, Cancer research.
[19] R. Lotan,et al. Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells. , 1986, Cancer research.
[20] S. Taniguchi,et al. [Cytoskeleton of cancer cells]. , 1986, Nihon rinsho. Japanese journal of clinical medicine.
[21] L. Liotta,et al. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. , 1985, The American journal of pathology.
[22] R. Lotan,et al. Inhibition of tumor cell colony formation in culture by a monoclonal antibody to endogenous lectins. , 1985, Cancer research.
[23] M. Oren,et al. Overproduction of p53 antigen makes established cells highly tumorigenic , 1985, Nature.
[24] G. Poste,et al. Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[25] V. Ling,et al. Selection for experimental metastatic ability of heterologous tumor cells in the chick embryo after DNA-mediated transfer. , 1984, Cancer research.
[26] R. Weinberg. Use of transfection to analyze genetic information and malignant transformation. , 1981, Biochimica et biophysica acta.
[27] R. Mulligan,et al. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Bucana,et al. Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential , 1980, Nature.
[29] H. Boedtker,et al. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.
[30] L. Liotta,et al. The significance of hematogenous tumor cell clumps in the metastatic process. , 1976, Cancer research.
[31] K. Weber,et al. Patterns of organization of actin and myosin in normal and transformed cultured cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[32] V. Freedman,et al. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.
[33] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[34] I. Fidler. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. , 1973, European journal of cancer.
[35] C. O'neill,et al. Anchorage and growth regulation in normal and virus‐transformed cells , 1968, International journal of cancer.
[36] R. A. Willis. The Spread of Tumours in the Human Body , 1934, Nature.
[37] A. Ben-Ze'ev,et al. The cytoskeleton in cancer cells. , 1985, Biochimica et biophysica acta.